(Q56835335)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10720685%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

title

A comparative analysis of generics markets in five European countries (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10720685%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10720685%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

author name string

L Garattini

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10720685%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

publication date

1 April 2000

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10720685%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10720685%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

volume

51

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10720685%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10720685%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

page(s)

149-162

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10720685%20AND%20SRC:MED&resulttype=core&format=json

An historical survey of UK government measures to control the NHS medicines expenditure from 1948 to 1996.

5 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8510%2800%2900061-0

7 January 2021

Generic medicines. Reducing cost at the expense of quality?

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8510%2800%2900061-0

7 January 2021

Bioequivalence requirements for generic products

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8510%2800%2900061-0

7 January 2021

A critical review of the remuneration systems for pharmacists

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8510%2800%2900061-0

7 January 2021

The German experience in reference pricing

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8510%2800%2900061-0

7 January 2021

What is Germany's experience on reference based drug pricing and the etiology of adverse health outcomes or substitution?

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8510%2800%2900061-0

7 January 2021

Consequences of implementing a drug budget for office-based physicians in Germany

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8510%2800%2900061-0

7 January 2021

Cultural shift in Italy's drug policy

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8510%2800%2900061-0

7 January 2021

The new pharmaceutical policy in Italy

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8510%2800%2900061-0

7 January 2021

Recent public policies in The Netherlands to control pharmaceutical pricing and reimbursement.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8510%2800%2900061-0

7 January 2021

The 1996 pricing and reimbursement policy in The Netherlands

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8510%2800%2900061-0

7 January 2021

Drug price divergence in Europe: regulatory aspects

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8510%2800%2900061-0

7 January 2021

The effects of fundholding in general practice on prescribing habits three years after introduction of the scheme

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8510%2800%2900061-0

7 January 2021

The new NHS: the second year. Budget holding: here to stay?

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8510%2800%2900061-0

7 January 2021

What do we known about fundholding in general practice?

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8510%2800%2900061-0

7 January 2021

Changing to generic formulary: how one fundholding practice reduced prescribing costs.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8510%2800%2900061-0

7 January 2021

The effect of fundholding on prescribing and referral costs: a review of the evidence.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8510%2800%2900061-0

7 January 2021

Fundholders' prescribing costs: the first five years

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8510%2800%2900061-0

7 January 2021

Introducing a market to the United Kingdom's National Health Service

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8510%2800%2900061-0

7 January 2021

How has fundholding in Northern Ireland affected prescribing patterns? A longitudinal study

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8510%2800%2900061-0

7 January 2021

Alterations in prescribing by general practitioner fundholders: an observational study

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8510%2800%2900061-0

7 January 2021

Prescribing costs in general practice fundholding

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8510%2800%2900061-0

7 January 2021

The pros and cons of generic medicines

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8510%2800%2900061-0

7 January 2021

10.1016/S0168-8510(00)00061-0

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10720685%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

1 reference